1 |
Deschoolmeester V, Baay M, Specenier P, et al (2010). A review of the most promising biomarkers in colorectal cancer: one step closer to targeted therapy. Oncologist, 15, 699-731.
DOI
|
2 |
Evan GI, Vousden KH (2001). Proliferation, cell cycle and apoptosis in cancer. Nature, 411, 342-8.
DOI
|
3 |
Fearon ER, Vogelstein B (1990). A genetic model for colorectal tumorigenesis. Cell, 61, 759-67.
DOI
|
4 |
Hanahan D, Weinberg RA (2011). Hallmarks of cancer: the next generation. Cell, 144, 646-74.
DOI
|
5 |
Hannon GJ, Casso D, Beach D (1994). KAP: a dual specificity phosphatase that interacts with cyclin-dependent kinases. Proc Natl Acad Sci USA, 91, 1731-5.
DOI
|
6 |
Ho A, Dowdy SF (2002). Regulation of G (1) cell-cycle progression by oncogenes and tumor suppressor genes. Curr Opin Genet Dev, 12, 47-52.
DOI
|
7 |
Lee SW, Reimer CL, Fang L, et al (2000). Overexpression of kinase-associated phosphatase (KAP) in breast and prostate cancer and inhibition of the transformed phenotype by antisense KAP expression. Mol Cell Biol, 20, 1723-32.
DOI
|
8 |
Livak KJ, Schmittgen TD (2001). Analysis of relative gene expression data using real-time quantitative PCR and the 2 (-Delta Delta C (T)) Method. Methods, 25, 402-8.
DOI
|
9 |
Niculescu MD, Yamamuro Y, Zeisel SH (2004). Choline availability modulates human neuroblastoma cell proliferation and alters the methylation of the promoter region of the cyclin-dependent kinase inhibitor 3 gene. J Neurochem, 89, 1252-9.
DOI
|
10 |
Orang AV, Barzegari A (2014). MicroRNAs in colorectal cancer: from diagnosis to targeted therapy. Asian Pac J Cancer Prev, 15, 6989-99.
DOI
|
11 |
Pino MS, Chung DC (2010). The chromosomal instability pathway in colon cancer. Gastroenterology, 138, 2059-72.
DOI
ScienceOn
|
12 |
Poon RY, Hunter T (1995). Dephosphorylation of Cdk2 Thr160 by the cyclin-dependent kinase-interacting phosphatase KAP in the absence of cyclin. Science, 270, 90-3.
DOI
|
13 |
Sherr CJ (2000). Cell cycle control and cancer. Harvey Lect, 96, 73-92.
|
14 |
Sherr CJ, Roberts JM (1999). CDK inhibitors: positive and negative regulators of G1-phase progression. Genes Dev, 13, 1501-12.
DOI
|
15 |
Siegel R, Desantis C, Jemal A (2014). Colorectal cancer statistics, 2014. CA Cancer J Clin, 64, 104-17.
DOI
ScienceOn
|
16 |
Tamgue O, Chai CS, Hao L, et al (2013). Triptolide inhibits histone methyltransferase EZH2 and modulates the expression of its target genes in prostate cancer cells. Asian Pac J Cancer Prev, 14, 5663-9.
DOI
|
17 |
Yeh CT, Lu SC, Chao CH, et al (2003). Abolishment of the interaction between cyclin-dependent kinase 2 and Cdkassociated protein phosphatase by a truncated KAP mutant. Biochem Biophys Res Commun, 305, 311-4.
DOI
|
18 |
Yeh CT, Lu SC, Chen TC, et al (2000). Aberrant transcripts of the cyclin-dependent kinase-associated protein phosphatase in hepatocellular carcinoma. Cancer Res, 60, 4697-700.
|
19 |
Zheng ZX, Zheng RS, Zhang SW, et al (2014). Colorectal cancer incidence and mortality in China, 2010. Asian Pac J Cancer Prev, 15, 8455-60.
DOI
|